Integrated Diagnostics Holdings Plc IDHC
The next Integrated Diagnostics Holdings Plc dividend is expected to go ex in 8 months and to be paid in 8 months.
The previous Integrated Diagnostics Holdings Plc dividend was 4.85c and it went ex 3 months ago and it was paid 2 months ago.
There is typically 1 dividend per year (excluding specials), and the dividend cover is approximately 2.0.
|Summary||Previous dividend||Next dividend|
|Per share||3.472p (4.85c)||Sign Up Required|
|Declaration date||19 May 2021 (Wed)||17 Mar 2022 (Thu)|
|Ex-div date||08 Jul 2021 (Thu)||12 May 2022 (Thu)|
|Pay date||29 Jul 2021 (Thu)||03 Jun 2022 (Fri)|
Enter the number of Integrated Diagnostics Holdings Plc shares you hold and we'll calculate your dividend payments:
Sign up for Integrated Diagnostics Holdings Plc and we'll email you the dividend information when they declare.
Add Integrated Diagnostics Holdings Plc to receive free notifications when they declare their dividends.
Your account is set up to receive Integrated Diagnostics Holdings Plc notifications.
|Status||Type||Decl. date||Ex-div date||Pay date||Decl. Currency||Forecast amount||Decl. amount||Accuracy|
|Forecast||Final||14 Mar 2024||09 May 2024||31 May 2024||USD||Sign up||—|
|Forecast||Final||16 Mar 2023||11 May 2023||02 Jun 2023||USD||Sign up||—|
|Forecast||Final||17 Mar 2022||12 May 2022||03 Jun 2022||USD||Sign up||—|
|Paid||Final||19 May 2021||08 Jul 2021||29 Jul 2021||USD||—||4.85c|
|Paid||Final||02 Sep 2020||10 Sep 2020||02 Oct 2020||USD||—||18.7c|
|Paid||Final||21 Mar 2019||16 May 2019||07 Jun 2019||USD||—||17.6c|
|Paid||Final||21 Mar 2018||17 May 2018||08 Jun 2018||USD||—||16c|
|Paid||Final||22 Mar 2017||11 May 2017||06 Jun 2017||USD||—||14c|
|Paid||Final||29 Mar 2016||07 Apr 2016||13 May 2016||USD||—||6c|
|2021||Sign Up Required|
|2022||Sign Up Required|
|2023||Sign Up Required|
Integrated Diagnostics Holdings Plc Optimized Dividend Chart
About Integrated Diagnostics Holdings Plc
Integrated Diagnostics Holdings plc is an integrated diagnostics services provider in Egypt. The Company operates in three geographic areas: Egypt, Sudan and Jordan. The Company provides over 1,000 diagnostic services ranging from basic tests to molecular tests for hepatitis and specialized deoxyribonucleic acid (DNA) tests to patients, and operates approximately 310 branches. The Company offers a range of services, such as Immunology, Radiology, Hematology, Endocrinology, Molecular Biology, Cytogenetics, Hatopathology and Microbiology. The Company's core brands include Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan, and Ultralab and Al Mokhtabar Sudan in Sudan. The Company also operates the Medical Genetics Centre brand in Egypt. Its Al Mokhtabar medical testing and diagnostic center provides services, including radiological tests, a center for allergy, a unit for nutritional advice, pre-employments tests, medical examination in different fields and checkup packages.
- Pharmaceuticals & Biotechnology
- United Kingdom
- Share Price
- £0.90 (yesterday's closing price)
- Shares in Issue
- 600 million
- Market Cap
- Market Indices